DaVita Inc. (NYSE:DVA) Holdings Trimmed by Lifeworks Advisors LLC

Lifeworks Advisors LLC lowered its position in shares of DaVita Inc. (NYSE:DVA) by 35.6% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 2,698 shares of the company’s stock after selling 1,491 shares during the period. Lifeworks Advisors LLC’s holdings in DaVita were worth $442,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of DVA. Texas Permanent School Fund Corp boosted its stake in DaVita by 5.6% during the first quarter. Texas Permanent School Fund Corp now owns 11,133 shares of the company’s stock valued at $1,537,000 after buying an additional 588 shares in the last quarter. Empowered Funds LLC acquired a new position in shares of DaVita in the 1st quarter valued at $404,000. Sei Investments Co. boosted its position in shares of DaVita by 21.3% in the 1st quarter. Sei Investments Co. now owns 41,952 shares of the company’s stock valued at $5,790,000 after purchasing an additional 7,371 shares during the period. State Board of Administration of Florida Retirement System boosted its position in shares of DaVita by 8.3% in the 1st quarter. State Board of Administration of Florida Retirement System now owns 73,574 shares of the company’s stock valued at $10,157,000 after purchasing an additional 5,625 shares during the period. Finally, Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in shares of DaVita by 13.5% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 61,570 shares of the company’s stock valued at $8,500,000 after purchasing an additional 7,300 shares during the period. Institutional investors own 90.12% of the company’s stock.

DaVita Stock Down 1.8 %

DVA opened at $154.38 on Friday. DaVita Inc. has a fifty-two week low of $91.87 and a fifty-two week high of $168.50. The business has a 50-day moving average of $157.57 and a 200-day moving average of $147.35. The company has a debt-to-equity ratio of 15.78, a current ratio of 1.37 and a quick ratio of 1.33. The company has a market capitalization of $12.66 billion, a PE ratio of 16.65, a price-to-earnings-growth ratio of 0.89 and a beta of 0.89.

DaVita (NYSE:DVA) last posted its quarterly earnings results on Tuesday, October 29th. The company reported $2.59 earnings per share for the quarter, missing analysts’ consensus estimates of $2.76 by ($0.17). DaVita had a return on equity of 88.18% and a net margin of 6.53%. The firm had revenue of $3.26 billion for the quarter, compared to analysts’ expectations of $3.25 billion. During the same period last year, the business earned $2.85 earnings per share. The firm’s revenue for the quarter was up 4.6% on a year-over-year basis. Equities research analysts forecast that DaVita Inc. will post 9.71 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

DVA has been the subject of a number of recent analyst reports. TD Cowen increased their price target on DaVita from $139.00 to $150.00 and gave the company a “hold” rating in a research report on Wednesday, July 24th. Barclays increased their price objective on DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 31st. Truist Financial increased their price objective on DaVita from $165.00 to $175.00 and gave the stock a “hold” rating in a research note on Monday, October 7th. Bank of America increased their price objective on DaVita from $139.00 to $145.00 and gave the stock an “underperform” rating in a research note on Wednesday, August 7th. Finally, UBS Group increased their price objective on DaVita from $169.00 to $175.00 and gave the stock a “buy” rating in a research note on Thursday, August 8th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $161.80.

Insider Transactions at DaVita

In other news, CEO Javier Rodriguez sold 50,000 shares of the stock in a transaction dated Monday, September 16th. The stock was sold at an average price of $165.05, for a total transaction of $8,252,500.00. Following the transaction, the chief executive officer now owns 837,835 shares of the company’s stock, valued at approximately $138,284,666.75. This represents a 5.63 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Joel Ackerman sold 64,029 shares of the stock in a transaction dated Tuesday, August 27th. The shares were sold at an average price of $155.06, for a total value of $9,928,336.74. Following the transaction, the chief financial officer now directly owns 111,481 shares in the company, valued at approximately $17,286,243.86. This represents a 36.48 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 156,086 shares of company stock valued at $24,807,161 in the last three months. Corporate insiders own 2.00% of the company’s stock.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.